Protein Hydrolysis Enzymes - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The global protein hydrolysis enzymes market was valued at USD 2.67 billion in 2025 and is projected to reach USD 2.81 billion in 2026, further expanding to USD 3.78 billion by 2031, registering a CAGR of 6.13% during 2026-2031. This report is Segmented by Source (Animal Protein, Plant Protein, and Microorganisms), Form (Liquid and Powder), Application (Food and Beverages, Detergent and Cleansing, Pharmaceutical, Animal Feed, Textile and Leather, and Others), and Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Market Forecasts are Provided in Value (USD).

Global Protein Hydrolysis Enzymes Market Trends and Insights

Demand for high-protein and functional food products

The growing demand for high-protein and functional food products is a major driver of the protein hydrolysis enzymes market. Food manufacturers increasingly require enzymatic technologies to modify protein structures and enhance ingredient functionality. Protein hydrolysis enzymes break intact proteins into smaller peptides and amino acids, improving solubility, digestibility, dispersibility, emulsification, foaming, and water-binding properties. This enables the development of high-performance protein ingredients for modern food formulations. Compared to conventional protein ingredients, hydrolyzed proteins produced through enzymatic processing offer superior functional characteristics. These properties support their incorporation into beverages, dairy products, protein powders, nutritional bars, clinical nutrition products, infant formula, bakery products, and specialized nutritional formulations without significantly affecting texture or processing efficiency.

Increasing utilization in infant and medical nutrition formulations

The increasing use of protein hydrolysis enzymes in infant and medical nutrition formulations is a significant driver of the protein hydrolysis enzymes market. These enzymes enable the production of partially and extensively hydrolyzed proteins with improved digestibility and reduced allergenic potential. Controlled enzymatic hydrolysis breaks down complex milk and other dietary proteins into smaller peptides that are easier to absorb. These peptides are widely used in specialized infant formulas, enteral nutrition products, and clinical nutritional supplements. The ability to precisely control the degree of hydrolysis allows manufacturers to produce formulations that meet stringent nutritional and regulatory specifications while maintaining consistent protein quality and functionality. Demand for these specialized formulations continues to grow alongside infant nutrition requirements. For instance, according to the World Bank, India's total fertility rate stood at 1.96 children per woman in 2024, indicating a substantial and continuous need for infant nutrition products in one of the world's largest birth cohorts.

High production and purification costs of specialty enzymes

High production and purification costs of specialty enzymes remain a significant restraint on the protein hydrolysis enzymes market. Manufacturing high-performance proteolytic enzymes requires sophisticated fermentation systems, downstream purification technologies, and rigorous quality control procedures. Production involves multiple stages, including microbial strain development, controlled fermentation, enzyme recovery, concentration, purification, stabilization, and formulation, each adding to operational complexity and manufacturing costs. Achieving high enzyme purity and consistent activity often requires advanced filtration, ultrafiltration, chromatography, and drying technologies, particularly for enzymes intended for food, pharmaceutical, and clinical nutrition applications where stringent quality standards must be met. Maintaining sterile production environments, validating batch consistency, and complying with regulatory requirements further increase production expenses.

Other drivers and restraints analyzed in the detailed report include:

• Expansion of plant-based protein ingredient manufacturing
• Advancements in enzyme engineering improving efficiency and specificity
• Strict regulatory requirements for approval and food safety

Segment Analysis

Microorganisms accounted for 51.23% of the market value by source in 2025. The segment maintains its leading position due to the ability of microbial strains to produce highly specific proteolytic enzymes with consistent activity and high purity. Microbial enzyme production enables controlled fermentation under standardized conditions, allowing manufacturers to achieve uniform hydrolysis performance while maintaining stringent quality specifications. Regulatory confidence in microbial enzymes continues to strengthen market adoption; for instance, the European Food Safety Authority (EFSA) updated the safety evaluation of a microbial food enzyme for use across 11 food manufacturing processes, reinforcing the acceptance of microbial enzyme technologies and supporting continued market growth.

Plant-derived protein hydrolysis enzymes are projected to expand at a CAGR of 7.87% during 2026-2031. Growth is supported by increasing innovation in naturally sourced enzymes such as papain, bromelain, and ficin, which offer broad substrate specificity and effective proteolytic activity under mild processing conditions. These enzymes are valued for their ability to preserve protein functionality while reducing harsh processing requirements, making them suitable for manufacturers seeking naturally derived processing aids. Ongoing research aimed at improving enzyme stability, extraction efficiency, and catalytic performance is further enhancing the commercial viability of plant-derived enzymes. In addition, advancements in sustainable cultivation and extraction technologies are improving the consistency and availability of botanical enzyme sources, strengthening the long-term growth outlook for this segment.

Complete Report Scope:

• By Source
  • Animal Protein
  • Plant Protein
  • Microorganisms
• By Form
  • Liquid
  • Powder
• By Application
  • Food and Beverages
  • Detergent and Cleansing
  • Pharmaceutical
  • Animal Feed
  • Textile and Leather
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • South America
  • Middle East and Africa

Geography Analysis

North America accounted for 32.12% of the global protein hydrolysis enzymes market value in 2025, maintaining its leading regional position. The region benefits from a well-established industrial biotechnology ecosystem, advanced enzyme manufacturing capabilities, and widespread adoption of precision fermentation technologies. Strong integration between enzyme developers, biotechnology research institutions, and large-scale manufacturing facilities supports continuous innovation in enzyme engineering and commercial production. Highly automated production infrastructure and stringent quality management systems further enable manufacturers to produce high-performance protein hydrolysis enzymes with consistent quality and scalability.

Asia-Pacific is projected to register the fastest CAGR of 7.61% during 2026-2031. The region's growth is supported by the rapid expansion of industrial enzyme manufacturing capacity, increasing investments in microbial fermentation infrastructure, and the development of biotechnology parks and life science clusters. Countries across the region continue to strengthen domestic enzyme production through advancements in fermentation technology, bioprocess optimization, and research collaborations between academia and industry. Expanding contract manufacturing capabilities and growing availability of skilled biotechnology expertise are also enhancing regional competitiveness in global enzyme production.

Europe, South America, and the Middle East and Africa continue to strengthen their positions through advancements in industrial biotechnology and enzyme manufacturing capabilities. Europe remains a key center for enzyme research, supported by strong regulatory oversight, continuous innovation in microbial strain development, and investments in sustainable bioprocessing technologies. South America is gradually expanding fermentation-based manufacturing, supported by its abundant agricultural feedstocks used in industrial biotechnology. The Middle East and Africa are witnessing increasing investments in biotechnology infrastructure and industrial diversification initiatives that are fostering the adoption and local production of specialty enzymes.

List of Companies Covered in this Report:

• Novonesis A/S
• dsm-firmenich AG
• International Flavors & Fragrances Inc.
• Kerry Group plc
• Amano Enzyme Inc.
• BASF SE
• Associated British Foods plc
• DuPont de Nemours, Inc.
• Advanced Enzyme Technologies Limited
• AB Enzymes GmbH
• Dyadic International, Inc.
• Specialty Enzymes and Biotechnologies Co.
• Biocatalysts Ltd.
• Solvay S.A.
• Chr. Hansen Holding A/S
• Jiangsu Boli Bioproducts Co., Ltd.
• Rossari Biotech Limited
• Enzyme Development Corporation
• Aumgene Biosciences
• Enzybel International S.A.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support